middle.news
Anatara Pauses IBS Trial Recruitment Ahead of Crucial Q1 2025 Results
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Anatara Pauses IBS Trial Recruitment Ahead of Crucial Q1 2025 Results
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Recruitment paused with 71 participants enrolled in Stage 2 of GaRP-IBS trial
Headline trial results anticipated in March 2025
New anti-obesity project initiated with pre-clinical studies underway
Raised $1.02 million through placement and share purchase plan
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE